Found 22 matching trials
PSMA-RLT in Biochemically Recurrent PCa PHASE2 Prospective single-center one-arm phase II study in patients with prostate ...
Show More Location
Medical University of Vienna
Learn More & Join Trial
Phase Ib Trial of 177Lu-PSMA-I&T Therapy in Combination With Olaparib and Pembrolizumab in Patients With Metastatic Castration Resistant Prostate Cancer PHASE1 This phase 1b trial is designed to evaluate the safety and tolerability of ...
Show More Location
Peter MacCallum Cancer Centre
Learn More & Join Trial
177Lu-PSMA-I&T PSMA Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer PHASE2 The purpose of this study is to determine the safety and efficacy of 177 Lu...
Show More Location
Nanjing First Hospital
Learn More & Join Trial
PSMA Therapy and Immunotherapy in Kidney Cancer PHASE1 This is a multi-center, single arm open label phase 1b/2 study of pembroliz...
Show More Location
Multiple Locations
Learn More & Join Trial
Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment PHASE3 The purpose of this study is to evaluate the efficacy and safety of \[Lu-17...
Show More Status
Active Not Recruiting
Location
Arizona Institute of Urology (AIU) - Tucson
Learn More & Join Trial
Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy PHASE2 The aim of this study is to assess the progression free survival (PFS) of S...
Show More Location
Royal North Shore
Learn More & Join Trial
177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study PHASE2 This phase II trial tests whether 177-Lutetium-PSMA given before stereotact...
Show More Status
Active Not Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
Neoadjuvant PSMA-RLT in Oligometastatic PCa PHASE2 Prospective single-center phase II study to evaluate the PSA, imaging and p...
Show More Location
Medical University of Vienna
Learn More & Join Trial
Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients PHASE2 Phase 2 pilot study, which evaluates the safety and efficacy of Lutetium-17...
Show More Learn More & Join Trial
Performance of 177Lu-PSMA-I&T for RLT in mCRPC - Prospective Multicenter Swiss Registry Study N/A The goal of this observational study (multicenter, national registry-based)...
Show More Location
University Hospital Basel
Learn More & Join Trial